Literature DB >> 20225201

Possible mechanisms of trichosanthin-induced apoptosis of tumor cells.

Meng Li1, Xiang Li, Ji-Cheng Li.   

Abstract

Trichosanthin (TCS) is a type I ribosome-inactivating protein that is isolated from the root tubers of the Chinese medicinal herb Trichosanthes kirilowii Maximowicz. TCS has been used as an abortifacient for 1,500 years in China because of its high toxicity on trophoblasts. Over the past 20 years, TCS has been the subject of much research because of its potential antitumor activities. Many reports have revealed that TCS is cytotoxic in a variety of tumor cell lines in vitro and in vivo. Monoclonal antibody-conjugated TCS could enhance its antitumor efficacy; thus, TCS is considered to be a potential biological agent for cancer treatment. TCS is able to inhibit protein synthesis and consequently induce necrosis. Recent studies have demonstrated that TCS does indeed induce apoptosis in several tumor cell lines. Although TCS-induced apoptosis of tumor cell lines is now well known, the underlying mechanisms remain to be elucidated. The purpose of this review was to investigate the effects of TCS and its possible mechanisms of action, based on published literature and the results of our own studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225201     DOI: 10.1002/ar.21142

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  12 in total

Review 1.  Improved Protein Toxin Delivery Based on ATTEMPTS Systems.

Authors:  Yingzhi Chen; Meng Zhang; Kyoung Ah Min; Huiyuan Wang; Meong Cheol Shin; Feng Li; Victor C Yang; Yongzhuo Huang
Journal:  Curr Drug Targets       Date:  2018-02-19       Impact factor: 3.465

2.  Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.

Authors:  Yuchan Cai; Shudao Xiong; Yijie Zheng; Feifei Luo; Pei Jiang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2011-05-16       Impact factor: 11.530

Review 3.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

4.  SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.

Authors:  Hyeong Sim Choi; Min Kyoung Kim; Kangwook Lee; Kang Min Lee; Youn Kyung Choi; Yong Cheol Shin; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Oncotarget       Date:  2016-05-31

5.  Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.

Authors:  Yingzhi Chen; Meng Zhang; Hongyue Jin; Dongdong Li; Fan Xu; Aihua Wu; Jinyu Wang; Yongzhuo Huang
Journal:  Theranostics       Date:  2017-08-15       Impact factor: 11.556

6.  Pokeweed antiviral protein increases HIV-1 particle infectivity by activating the cellular mitogen activated protein kinase pathway.

Authors:  Sheila Mansouri; Meherzad Kutky; Katalin A Hudak
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

7.  Cyclic AMP-response element regulated cell cycle arrests in cancer cells.

Authors:  Ping Wang; Shuaishuai Huang; Feng Wang; Yu Ren; Michael Hehir; Xue Wang; Jie Cai
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 8.  Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.

Authors:  Ou Sha; Junfei Niu; Tzi-Bun Ng; Eric Yu-Pang Cho; Xiaoyuan Fu; Wenqi Jiang
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

9.  Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis.

Authors:  Evandro Fei Fang; Chris Zhi Yi Zhang; Lin Zhang; Jack Ho Wong; Yau Sang Chan; Wen Liang Pan; Xiu Li Dan; Cui Ming Yin; Chi Hin Cho; Tzi Bun Ng
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells.

Authors:  Chengcheng You; Yingming Sun; Shiyu Zhang; Guiliang Tang; Nannan Zhang; Chunyang Li; Xiaoli Tian; Shijing Ma; Yuan Luo; Wenjie Sun; Feng Wang; Xuefeng Liu; Yu Xiao; Yan Gong; Junhong Zhang; Conghua Xie
Journal:  Int J Biol Sci       Date:  2018-02-09       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.